Seroyal International, a division of Atrium Innovations
Seroyal International, a division of Atrium Innovations appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (F-1756-2018, Class II) was initiated on July 27, 2018.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| F-1756-2018 | Class II | Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules | July 27, 2018 |